Methionine Addiction: The Fundamental Hallmark Of Cancer | RESEARCH MANAGEMENT CENTRE
» ARTICLE » Methionine Addiction: The Fundamental Hallmark of Cancer

Methionine Addiction: The Fundamental Hallmark of Cancer

Free Cancer Research Webinar

Methionine Addiction:

The Fundamental Hallmark of Cancer

From discovery 44 years ago to the present excitement

  • Wednesday, 16th December 2020
  • 9:00 AM (CST)

Dr. Robert M. Hoffman

  • 55+ years in cancer research
  • 1100+ scientific publications
  • 52283 citations
  • Pioneered Hoffman Effect

SESSION AGENDA

Enago in collaboration with AntiCancer, Inc.—the world’s leading preclinical cancer contract research organization—is glad to announce an advanced session on cancer research studies. Dr. Robert M. Hoffman (President, Chairman of Board and CEO, AntiCancer, Inc.), a veteran scientist who discovered the methionine addiction of cancer (Hoffman Effect), will describe the mechanism of the methionine addiction and how this fundamental hallmark of all cancers can be targeted therapeutically.

With 55+ years of significant contribution to science, Dr. Hoffman has conducted pioneering research studies to provide treatment for cancer. His session will focus on discussing the following key topics related to methionine addiction:

 

What is the Hoffman effect?

Everything about methionine addiction and its importance in cancer

Role of methylation and transmethylation reactions

Which is the most powerful form of PET imaging in cancer?

Cancer treatment using methionine restriction

 

WHO SHOULD ATTEND THIS SESSION?

Cancer Researchers and Scientists

Doctors and Clinicians

Health Care Professionals

Oncology Societies and Cancer Institute

 

Register now at https://www.enago.com/academy/hoffman-effect-cancer-webinar/?source=APAC&utm_medium=APACemail

Date of Input: 09/12/2020 | Updated: 09/12/2020 | engkuliyana

MEDIA SHARING

RESEARCH MANAGEMENT CENTRE
Universiti Putra Malaysia
43400 UPM Serdang
Selangor Darul Ehsan
03-9769 1610
03-9769 1610
BVMGSsP:18:44